View Older Stories View More Recent Stories

Sep 18, 2024 01:30PM Cosmos Health Releases 2024-2027 Updated Guidance; Projects Revenue of $155.8M and Adjusted EBITDA of $29.4M Annually by 2027, Driven by Strategic Focus on High-Margin Segments

Sep 17, 2024 11:45AM Taglich Brothers Publishes Updated Coverage Report on Cosmos Health; Maintains Price Target of $4, Nearly 300% Above Current Share Price

Sep 16, 2024 08:33AM Cosmos Health (COSM) Secures Exclusivity Agreement with Virax Biolabs (VRAX) to Distribute mpox PCR Kits across the GCC

Sep 16, 2024 08:32AM Virax Biolabs Group (VRAX) Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc.

Sep 16, 2024 08:30AM Cosmos Health Secures Exclusivity Agreement with Virax Biolabs to Distribute mpox PCR Kits across the GCC, including the UAE, Saudi Arabia, Bahrain, Kuwait, Oman, and Qatar

Aug 23, 2024 09:38AM Cosmos Health (COSM) Regains Full Compliance with Nasdaq Listing Requirements

Aug 23, 2024 09:35AM Cosmos Health Regains Full Compliance with Nasdaq Listing Requirements

Aug 21, 2024 11:23AM Cosmos Health's (COSM) Cana Laboratories Completes Facility Upgrades and Secures Contract Manufacturing Agreement with Provident Pharmaceuticals for 4.32 Million Vials of DE3-SOLE

Aug 21, 2024 10:41AM Cosmos Health's Cana Laboratories Completes Facility Upgrades and Secures Contract Manufacturing Agreement with Provident Pharmaceuticals for 4.32 Million Vials of DE3-SOLE

Aug 21, 2024 10:25AM Cosmos Health (COSM) Holds EU Distribution Rights for Virax Biolabs’ Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits

Aug 21, 2024 10:20AM Cosmos Health Holds EU Distribution Rights for Virax Biolabs’ Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits

Aug 20, 2024 12:20PM Cosmos Health Reports Q2 2024 Results: Sustains Positive Momentum with 7% Revenue Growth vs. Q1 2023 and 12.5% vs. H1 2023

Aug 20, 2024 09:00AM Cosmos Health Reports Q1 2024 Results: Continues to Deliver Strong Growth and Improved Performance with 18% YoY Revenue Increase and 39% Rise in Gross Profit

Aug 8, 2024 01:03PM Cosmos Health (COSM) Completes Registration Process in Germany to Commence Sales of its C-Scrub Antimicrobial Wash

Aug 8, 2024 01:00PM Cosmos Health Completes Registration Process in Germany to Commence Sales of its C-Scrub Antimicrobial Wash; Enters $750M+ Market

Aug 6, 2024 09:00AM Cosmos Health Reports Full Year 2023 Results: Revenue Increases to $53.4M, or 6% YoY; Stockholders' Equity Remains Near Record Highs at $36M, or $2.25 per Share

Jul 25, 2024 05:00PM Cosmos Health Signs Distribution Agreement with ProMed Trading for Its Sky Premium Life Food Supplements in Qatar

Jul 25, 2024 02:45PM Cosmos Health Successfully Submits Tender for C-Scrub Wash Chlorhexidine 4% to Supply NHS Scotland

Jul 25, 2024 11:50AM Cosmos Health (COSM) Signs Distribution Agreement with ProMed Trading

Jul 24, 2024 05:00PM Cosmos Health Updates on Contract Manufacturing Division; Completes Phase I of Production Capacity Expansion, Positioned to Generate Over $10M in Annual Gross Profit at Full Capacity

Jul 24, 2024 10:57AM Cosmos Health (COSM) Updates on Contract Manufacturing Division

Jul 19, 2024 12:13PM Cosmos Health (COSM) Regains Compliance with Nasdaq Minimum Bid Price Rule

Jul 18, 2024 04:31PM Cosmos Health's (COSM) Cana Secures Additional Contract Manufacturing Agreement with Provident Pharmaceuticals

Jul 18, 2024 03:45PM Cosmos Health's Cana Secures Additional Contract Manufacturing Agreement with Provident Pharmaceuticals for 700,000 Units, Bringing Total Order Book to 5.02 Million Units

Jul 18, 2024 11:40AM Cosmos Health Regains Compliance with Nasdaq Minimum Bid Price Rule

Jul 10, 2024 03:46PM Cosmos Health (COSM) Advances Commercialization of CCX0722 Weight Management Solution

Jul 10, 2024 03:45PM Cosmos Health Advances Commercialization of CCX0722 Weight Management Solution with Completion of Pilot Production and Scale-Up Phases; Significant Step Towards Entering $143Bn Global Market

Jul 9, 2024 02:03PM Cosmos Health's (COSM) Cana Secures Contract Manufacturing Agreement with Australia's Humacology for up to 500,000 CBD Units Annually

Jul 9, 2024 02:00PM Cosmos Health's Cana Secures Contract Manufacturing Agreement with Australia's Humacology for up to 500,000 CBD Units Annually

Jul 2, 2024 03:33PM Cosmos Health (COSM) Expands Collaboration with Papaellinas in Cyprus; Sky Premium Life Sales Expected to More Than Double to 150,000 Units Over Next 12 Months

Jul 2, 2024 03:30PM Cosmos Health Expands Collaboration with Papaellinas in Cyprus; Sky Premium Life Sales Expected to More Than Double to 150,000 Units Over Next 12 Months

Jul 1, 2024 11:20AM Cosmos Health Signs Distribution Agreement with ZENDON s.r.o. in Slovakia, Hungary, Poland, and Czechia for Its Sky Premium Life Nutraceutical Products; Gains Access to More than 6,000 Stores of Leadi

Jun 27, 2024 04:17PM Cosmos Health (COSM) Signs Exclusive Distribution Agreement with Pharmalink

Jun 27, 2024 03:45PM Cosmos Health Signs Exclusive Distribution Agreement with Pharmalink for Its Sky Premium Life Nutraceuticals in the UAE; Receives Initial Purchase Order for 130,000 Units

Jun 18, 2024 10:05AM Cosmos Health (COSM) to Acquire Remaining Rights to WIPO-Filed CNS Cancer Drug Patent

Jun 18, 2024 10:00AM Cosmos Health Strengthens Global Brain Tumor Market Position by Entering Agreement to Acquire Remaining Rights to WIPO-Filed CNS Cancer Drug Patent

Jun 13, 2024 09:25AM Cosmos Health Completes Acquisition of Pelofarm's Pharmacy Distribution Network; Annual Revenue Poised to Grow by Over $5 Million

View More Recent Stories View Older Stories